X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (22) 22
Publication (8) 8
Book / eBook (6) 6
Book Chapter (1) 1
Conference Proceeding (1) 1
Dissertation (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (13) 13
humans (12) 12
animals (10) 10
female (8) 8
mice (8) 8
cell line, tumor (6) 6
medicine (6) 6
article (5) 5
breast cancer (5) 5
cancer (5) 5
drug delivery systems (4) 4
drugs (4) 4
oncology (4) 4
pharmacology & pharmacy (4) 4
polymalic acid (4) 4
research (4) 4
antineoplastic agents - administration & dosage (3) 3
blood (3) 3
chemistry, multidisciplinary (3) 3
children (3) 3
cáncer (3) 3
electronic books (3) 3
health aspects (3) 3
immunotherapy (3) 3
lymphocytes t (3) 3
malates - chemistry (3) 3
male (3) 3
mice, nude (3) 3
neoplasms (3) 3
polymers - chemistry (3) 3
vehicles (3) 3
activation (2) 2
air pollution (2) 2
antibodies (2) 2
antigens (2) 2
antineoplastic agents (2) 2
antineoplastic agents - therapeutic use (2) 2
apoptosis (2) 2
biochemistry (2) 2
biology (2) 2
biopolymers (2) 2
blood-brain barrier (2) 2
blood-brain barrier - metabolism (2) 2
brain (2) 2
brain neoplasms - genetics (2) 2
brain neoplasms - pathology (2) 2
brain tumors (2) 2
breast-cancer (2) 2
cancer therapies (2) 2
cells (2) 2
chemotherapy (2) 2
child care (2) 2
clinical trials (2) 2
colorectal cancer (2) 2
cytotoxicity (2) 2
delivery (2) 2
disease models, animal (2) 2
diseases (2) 2
drug carriers - chemistry (2) 2
drug delivery (2) 2
drug design (2) 2
drug therapy (2) 2
drug-delivery (2) 2
early childhood education (2) 2
elementary schools (2) 2
english language (2) 2
gene expression (2) 2
growth-factor receptor (2) 2
immune system (2) 2
immunization (2) 2
immunoconjugates - pharmacokinetics (2) 2
immunology (2) 2
in-vivo (2) 2
inflammation (2) 2
inhibition (2) 2
kinases (2) 2
laminin-411 (2) 2
lymphocytes (2) 2
malic acid (2) 2
medical research (2) 2
metodología (2) 2
multidisciplinary sciences (2) 2
nanobioconjugate (2) 2
nanoconjugates - chemistry (2) 2
nanomedicine - methods (2) 2
nanotechnology (2) 2
neoplasms - drug therapy (2) 2
physicians (2) 2
protein (2) 2
proteins (2) 2
quality (2) 2
receptor, epidermal growth factor - antagonists & inhibitors (2) 2
receptor, epidermal growth factor - metabolism (2) 2
receptor, erbb-2 - metabolism (2) 2
research article (2) 2
skin and connective tissue diseases (2) 2
teachers (2) 2
teenagers (2) 2
therapy (2) 2
toxicology (2) 2
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
Online Resources - Online (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Research, ISSN 0008-5472, 08/2015, Volume 75, Issue 15 Supplement, pp. 4057 - 4057
Journal Article
Journal of Gastrointestinal Oncology, ISSN 2078-6891, 2015, Volume 6, Issue 2, pp. 208 - 223
The development of cancer is a multi-step process involving the gradual loss of regulation over the growth and functional capabilities of normal cells. Much... 
Inflammation | Colorectal cancer (CRC) | Immunotherapy | Immune system | Rectal Cancer-current Therapies and Emerging Concepts | colorectal cancer (CRC) | Special Review | inflammation | immunotherapy
Journal Article
NATURE COMMUNICATIONS, ISSN 2041-1723, 08/2019, Volume 10, Issue 1, pp. 3850 - 13
Brain glioma treatment with checkpoint inhibitor antibodies to cytotoxic T-lymphocyte-associated antigen 4 (a-CTLA-4) and programmed cell death-1 (a-PD-1) was... 
SYSTEM | INTERLEUKIN-2 | PROTEIN | IMMUNOTHERAPY | MACROPHAGES | MULTIDISCIPLINARY SCIENCES | BLOCKADE | IDENTIFICATION | GLIOBLASTOMA ERADICATION | ANAPHYLAXIS | DELIVERY | Antineoplastic Agents, Immunological - administration & dosage | Biopolymers - chemistry | Antineoplastic Agents, Immunological - pharmacokinetics | Humans | Brain Neoplasms - pathology | Immunoconjugates - pharmacokinetics | Physarum polycephalum - chemistry | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Cell Line, Tumor - transplantation | Immunoconjugates - administration & dosage | Brain Neoplasms - immunology | Glioma - pathology | Female | Disease Models, Animal | Glioma - immunology | Treatment Outcome | Permeability | Brain Neoplasms - drug therapy | CTLA-4 Antigen - immunology | Immunoconjugates - chemistry | Blood-Brain Barrier - metabolism | Malates - chemistry | Animals | Polymers - chemistry | Mice | Programmed Cell Death 1 Receptor - immunology | CTLA-4 Antigen - antagonists & inhibitors | Glioma - drug therapy | Nanoconjugates - chemistry | Brain | PD-1 protein | CD8 antigen | Brain tumors | Brain cancer | Glioblastoma | Antibodies | Cytotoxicity | Activation | Lymphocytes T | Macrophages | Biopolymers | Blood | Bearing | CTLA-4 protein | Blood-brain barrier | Lymphocytes | Malic acid | Movement disorders | Immune system | Antigens | Cell survival | Immune response | Immunoregulation | Inhibitors | Immune checkpoint | Immunoconjugates | Glioma | Cell death | Tumors | Apoptosis
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2012, Volume 7, Issue 2, p. e31070
Treatment options for triple negative breast cancer (TNBC) are generally limited to cytotoxic chemotherapy. Recently, anti-epidermal growth factor receptor... 
GROWTH-FACTOR RECEPTOR | APOPTOSIS | IN-VITRO | TRANSFERRIN | MULTIDISCIPLINARY SCIENCES | ANTISENSE | ANTIBODY | TUMOR-CELLS | POLYMALIC ACID | LIPOSOMES | DELIVERY | Receptor, Epidermal Growth Factor - genetics | Receptors, Estrogen - metabolism | Humans | Receptor, ErbB-2 - metabolism | Antibodies, Monoclonal - therapeutic use | Antineoplastic Agents - therapeutic use | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Breast Neoplasms - therapy | Receptor, Epidermal Growth Factor - metabolism | Nanoparticles - therapeutic use | Oligonucleotides, Antisense - therapeutic use | Female | Tumor Cells, Cultured | Proto-Oncogene Proteins c-akt - metabolism | Signal Transduction | Blotting, Western | Xenograft Model Antitumor Assays | Malates - chemistry | Animals | Biopolymers - therapeutic use | Breast Neoplasms - genetics | Mice, Nude | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Polymers - chemistry | Mice | Drugs | Chemotherapy | Drug delivery systems | Biological products | Epidermal growth factor | Monoclonal antibodies | Malic acid | Breast cancer | Vehicles | Cancer | Phosphorylation | Transferrin | Downstream effects | Physicians | Cytotoxicity | Confocal microscopy | AKT protein | Drug delivery | Leucine | Confocal | Kinases | Biopolymers | Cancer therapies | Accumulation | Western blotting | Synthesis | Polyethylene glycol | Bioaccumulation | Video compression | Inhibition | Epidermal growth factor receptors | Antisense oligonucleotides | MPEG encoders | Microscopy | Breast
Journal Article
Cellular & Molecular Immunology, ISSN 1672-7681, 11/2012, Volume 9, Issue 6, p. 455
  Previously, we established a model in which physiologically adequate function of the autologous β cells was recovered in non-obese diabetic (NOD) mice after... 
Journal Article
ACS Nano, ISSN 1936-0851, 05/2015, Volume 9, Issue 5, pp. 5594 - 5608
Journal Article
Immunity, ISSN 1074-7613, 11/2018, Volume 49, Issue 5, pp. 873 - 885.e7
Receptor interacting protein 2 (RIP2) plays a role in sensing intracellular pathogens, but its function in T cells is unclear. We show that RIP2 deficiency in... 
atherosclerosis | Chlamydia pneumoniae | IL-17 | RORα | Th17 | chronic inflammation | RIP2 | T(H)17 CELLS | TGF-BETA | INNATE IMMUNE-RESPONSES | INFLAMMATION | HOST-DEFENSE | ATHEROSCLEROSIS | INFECTION | NOD2 | IMMUNOLOGY | NF-KAPPA-B | T-Lymphocyte Subsets - immunology | Encephalomyelitis, Autoimmune, Experimental - metabolism | T-Lymphocyte Subsets - cytology | Encephalomyelitis, Autoimmune, Experimental - etiology | Receptor-Interacting Protein Serine-Threonine Kinases - chemistry | Nuclear Receptor Subfamily 1, Group F, Member 1 - metabolism | Cell Differentiation - genetics | Inflammation - metabolism | Th17 Cells - metabolism | Atherosclerosis | Th17 Cells - cytology | Gene Expression | Encephalomyelitis, Autoimmune, Experimental - mortality | Immunophenotyping | Interleukin-1beta | Interleukin-17 - biosynthesis | Mice, Knockout | Receptor-Interacting Protein Serine-Threonine Kinases - genetics | Animals | T-Lymphocyte Subsets - metabolism | Biomarkers | Inflammation - genetics | Mice | Receptor-Interacting Protein Serine-Threonine Kinases - deficiency | Caspase Activation and Recruitment Domain | Oligomers | Medical research | Pneumonia | Interleukins | Bacterial pneumonia | Communicable diseases | Medicine, Experimental | Inflammation | Research institutes | T cells | Cell differentiation | Encephalomyelitis | Disease | Interleukin | Helper cells | Differentiation (biology) | Chronic infection | Infections | Lymphocytes T | Kinases | Proteins | Sexually transmitted diseases | Lymphocytes | Interleukin 1 | Chronic illnesses | Antigens | Oligomerization | Cytokines | Mortality | Gene expression | Experimental allergic encephalomyelitis | CD4 antigen | Lungs | Arteriosclerosis | RIP2, IL-17
Journal Article
中国免疫学杂志:英文版, ISSN 1672-7681, 2012, Volume 9, Issue 6, pp. 455 - 463
Previously, we established a model in which physiologically adequate function of the autologous β cells was recovered in non-obese diabetic (NOD) mice after... 
小鼠模型 | 淋巴结 | 细胞再生 | eg细胞 | 调节性T细胞 | 胰腺 | 自身免疫性疾病 | TID
Journal Article
Journal of Drug Targeting, ISSN 1061-186X, 12/2013, Volume 21, Issue 10, pp. 956 - 967
Journal Article
01/2016, ISBN 1369232160
Dissertation
Journal Article
Cellular and Molecular Immunology, ISSN 1672-7681, 11/2012, Volume 9, Issue 6, pp. 455 - 463
Journal Article
Technical Proceedings of the 2012 NSTI Nanotechnology Conference and Expo, NSTI-Nanotech 2012, 2012, pp. 261 - 264
Conference Proceeding
Journal of Controlled Release, ISSN 0168-3659, 11/2013, Volume 171, Issue 3, pp. 322 - 329
Journal Article